{"id":"W4322771858","doi":"10.1158/1538-7445.sabcs22-p1-11-19","title":"Abstract P1-11-19: A real-world evidence study of treatment patterns in patients with HER2-positive metastatic breast cancer who have received at least 2-lines of therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; AstraZeneca (Canada)","funders":"","keywords":"Medicine; Metastatic breast cancer; Pertuzumab; Trastuzumab; Discontinuation; Internal medicine; Oncology; Breast cancer; Cancer; Interquartile range","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005529338,0.0003527164,0.0009230554,0.0007867247,0.0001166064,0.00001568395,0.0002647531,0.00005140679,0.0005723294],"category_scores_gemma":[0.00004866051,0.0002505041,0.00009086938,0.001639638,0.0003600334,0.0002208913,0.0001094559,0.0003107174,0.000006107207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002671538,"about_ca_system_score_gemma":0.0009004189,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.109217,"about_ca_topic_score_gemma":0.1205015,"domain_scores_codex":[0.9962938,0.0003364989,0.0006191506,0.0007078472,0.001324902,0.0007177441],"domain_scores_gemma":[0.9971631,0.0005594397,0.0002951646,0.0006682147,0.001075932,0.0002381861],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01348923,0.001596601,0.9357432,0.000328549,0.0006134749,0.00007049322,0.008431774,0.001259833,0.002687207,0.000001571365,0.00006666702,0.03571136],"study_design_scores_gemma":[0.009747011,0.003102574,0.9737838,0.003125408,0.00006927489,0.000002449382,0.003789805,0.00004166784,0.006041879,0.00001048977,0.00008279445,0.000202869],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941273,0.0008223185,0.000002176657,0.0009332456,0.00005566228,0.003294397,0.0006799643,0.00003614371,0.00004875786],"genre_scores_gemma":[0.9924163,0.004413578,0.00001992851,0.00003864479,0.00009098333,0.001630583,0.00004143854,0.00008780684,0.001260749],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03804054,"threshold_uncertainty_score":0.9999947,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1398723184148304,"score_gpt":0.4563584420705444,"score_spread":0.3164861236557139,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}